Ghisallo Capital Management »

Summit Therapeutics shares owned by Ghisallo Capital Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Ghisallo Capital Management from 13F filings

Historical chart of Ghisallo Capital Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Ghisallo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Ghisallo Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.1M 350k 14.57

More positions owned by Ghisallo Capital Management

Space Exploration Techn Corp Class A Com Stk (SPCX)
Digital Realty Trust (DLR)
Midea 051333 Cvt Put Convertible Bond (Principal)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Super Micro Computer Com New (SMCI)
Medline Com Cl A (MDLN)
Nebius Group Shs Class A (NBIS)
Xpeng Ads (XPEV)
Midea 051127 Cvt Convertible Bond (Principal)
Aurora Innovation Class A Com (AUR)
Ztoec 0925 030131 Cvt Put Convertible Bond (Principal)
American Electric Power Company (AEP)
Forgent Power Solutions Com Shs Cl A (FPS)
Lnvgy 062533 Cvt Convertible Bond (Principal)

View all positions for Ghisallo Capital Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
T. Rowe Price Associates
State Street Corporation
Vanguard Capital Management
UBS Group
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Geode Capital Management
Citadel Advisors
Susquehanna International
Millennium Management
Adage Capital Partners GP

View all funds holding Summit Therapeutics